Long-term IKK2/NF-κB signaling in pancreatic β-cells induces immune-mediated diabetes

Diabetes

Volumn 63, Issue 3, 2014, Pages 960-975

  Salem, Heba H ^a,b   Trojanowski, Bernadette ^a   Fiedler, Katja ^a   Maier, Harald J ^a   Schirmbeck, Reinhold ^c   Wagner, Martin ^c   Boehm, Bernhard O ^c,d   Wirth, Thomas ^a   Baumann, Bernd ^a  

^a UNIVERSITY OF ULM   (Germany)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; APOPTOSIS; CHEMOKINE CCL17; CHEMOKINE CCL22; DIABETES MELLITUS, TYPE 1; ENDOPLASMIC RETICULUM STRESS; HOMEODOMAIN PROTEINS; I-KAPPA B KINASE; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTOME;

EID: 84894430346     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1037     Document Type: Article

References (50)

1. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010;464:1293-1300
2. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and betacell loss in type 1 diabetes. Nat Rev Endocrinol 2009;5:219-226
3. Baker RG, Hayden MS, Ghosh S. NF-kB, inflammation, and metabolic disease. Cell Metab 2011;13:11-22
4. Baumann B, Salem HH, Boehm BO. Anti-inflammatory therapy in type 1 diabetes. Curr Diab Rep 2012;12:499-509
5. Zhao Y, Krishnamurthy B, Mollah ZU, Kay TW, Thomas HE. NF-kB in type 1 diabetes. Inflamm Allergy Drug Targets 2011;10:208-217
6. Holland AM, Hale MA, Kagami H, Hammer RE, MacDonald RJ. Experimental control of pancreatic development and maintenance. Proc Natl Acad Sci USA 2002;99:12236-12241
7. Baumann B, Wagner M, Aleksic T, et al. Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. J Clin Invest 2007; 117:1502-1513
8. Lattke M, Magnutzki A, Walther P, Wirth T, Baumann B. Nuclear factor kB activation impairs ependymal ciliogenesis and links neuroinflammation to hydrocephalus formation. J Neurosci 2012;32:11511-11523
9. Rajasalu T, Brosi H, Schuster C, et al. Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells. Diabetes 2010;59:1966-1973
10. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985;313: 353-360
11. Sarkar SA, Lee CE, Victorino F, et al. Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes 2012;61: 436-446
12. Planas R, Carrillo J, Sanchez A, et al. Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes. Clin Exp Immunol 2010;159: 23-44
13. Eizirik DL, Sammeth M, Bouckenooghe T, et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 2012;8:e1002552
14. Ylipaasto P, Kutlu B, Rasilainen S, et al. Global profiling of coxsackievirusand cytokine-induced gene expression in human pancreatic islets. Diabetologia 2005;48:1510-1522
15. Ylipaasto P, Smura T, Gopalacharyulu P, et al. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction. Diabetologia 2012;55:3273-3283
16. Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005;54(Suppl. 2):S97-S107
17. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008;29:42-61
18. Tersey SA, Nishiki Y, Templin AT, et al. Islet b-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 2012;61:818-827
19. Marhfour I, Lopez XM, Lefkaditis D, et al. Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 2012;55:2417-2420
20. Kim SH, Cleary MM, Fox HS, Chantry D, Sarvetnick N. CCR4-bearing T cells participate in autoimmune diabetes. J Clin Invest 2002;110: 1675-1686
21. Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK. Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 2011;33:9-21
22. Bertho N, Drénou B, Laupeze B, et al. HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC. J Immunol 2000;164:2379-2385
23. Dotta F, Censini S, van Halteren AG, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007;104:5115-5120
24. Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest 2000;105: 459-468
25. Phillips JM, Parish NM, Raine T, et al. Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by nondepleting antibodies targeting both T cell populations. Rev Diabet Stud 2009;6:97-103
26. Eldor R, Yeffet A, Baum K, et al. Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci USA 2006;103:5072-5077
27. Ueberberg S, Deutschbein T, Klein HH, et al. Protection from diabetes development by single-chain antibody-mediated delivery of a NF-kB inhibitor specifically to b-cells in vivo. Am J Physiol Endocrinol Metab 2011; 301:E83-E90
28. Laybutt DR, Weir GC, Kaneto H, et al. Overexpression of c-Myc in beta-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes. Diabetes 2002;51:1793-1804
29. Allagnat F, Fukaya M, Nogueira TC, et al. C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in b-cells. Cell Death Differ 2012;19:1836-1846
30. Moore F, Naamane N, Colli ML, et al. STAT1 is a master regulator of pancreatic beta-cell apoptosis and islet inflammation. J Biol Chem 2011; 286:929-941
31. Newsholme P, Morgan D, Rebelato E, et al. Insights into the critical role of NADPH oxidase(s) in the normal and dysregulated pancreatic beta cell. Diabetologia 2009;52:2489-2498
32. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 1990;71:152-156
33. Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010;6:279-289
34. Liu D, Cardozo AK, Darville MI, Eizirik DL. Double-stranded RNA cooperates with interferon-gamma and IL-1 beta to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic beta-cells: potential mechanisms for viral-induced insulitis and beta-cell death in type 1 diabetes mellitus. Endocrinology 2002;143:1225-1234
35. Heinig M, Petretto E, Wallace C, et al.; Cardiogenics Consortium. A transacting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 2010;467:460-464
36. Colli ML, Moore F, Gurzov EN, Ortis F, Eizirik DL. MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA. Hum Mol Genet 2010;19: 135-146
37. Nakayama T, Hieshima K, Nagakubo D, et al. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 2004;78:1665-1674
38. Jung MR, Lee TH, Bang MH, et al. Suppression of thymus-and activationregulated chemokine (TARC/CCL17) production by 3-O-b-D- glucopyanosylspinasterol via blocking NF-kB and STAT1 signaling pathways in TNF-a and IFN-g-induced HaCaT keratinocytes. Biochem Biophys Res Commun 2012;427:236-241
39. Alferink J, Lieberam I, Reindl W, et al. Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J Exp Med 2003;197:585-599
40. Hartl D, Lee CG, Da Silva CA, Chupp GL, Elias JA. Novel biomarkers in asthma: chemokines and chitinase-like proteins. Curr Opin Allergy Clin Immunol 2009;9:60-66
41. Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/ CCL17 and skin diseases. J Dermatol Sci 2006;43:75-84
42. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002;38:881-885
43. Montane J, Bischoff L, Soukhatcheva G, et al. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. J Clin Invest 2011;121:3024-3028
44. Aso Y, Matsuura H, Momobayashi A, et al. Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' disease. Endocr J 2006;53: 377-385
45. Gupta SK, Haigh BJ, Griffin FJ, Wheeler TT. The mammalian secreted RNases: mechanisms of action in host defence. Innate Immun 2013;19: 86-97
46. Bosco D, Meda P, Morel P, et al. Expression and secretion of alpha1-proteinase inhibitor are regulated by proinflammatory cytokines in human pancreatic islet cells. Diabetologia 2005;48:1523-1533
47. Koulmanda M, Bhasin M, Fan Z, et al. Alpha 1-antitrypsin reduces inflammation and enhances mouse pancreatic islet transplant survival. Proc Natl Acad Sci USA 2012;109:15443-15448
48. Zhang B, Lu Y, Campbell-Thompson M, et al. Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes 2007;56:1316-1323
49. Koulmanda M, Bhasin M, Hoffman L, et al. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci USA 2008;105:16242-16247
50. Lisowska-Myjak B. AAT as a diagnostic tool. Clin Chim Acta 2005; 352:1-13